Camber Capital Management’s Biolase, Inc. BIOL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-427
Closed -$3.21M 37
2017
Q3
$3.21M Hold
427
0.2% 23
2017
Q2
$5.17M Hold
427
0.25% 33
2017
Q1
$7.2M Hold
427
0.29% 28
2016
Q4
$7.46M Buy
+427
New +$8.45M 0.39% 31
2016
Q3
Sell
-427
Closed -$6.24M 43
2016
Q2
$6.24M Hold
427
0.3% 39
2016
Q1
$6.99M Hold
427
0.41% 38
2015
Q4
$4.49M Hold
427
0.29% 39
2015
Q3
$4.8M Hold
427
0.41% 38
2015
Q2
$9.28M Sell
427
-164
-28% -$4M 0.63% 35
2015
Q1
$11.3M Buy
591
+147
+33% +$4.16M 0.81% 29
2014
Q4
$14.6M Buy
444
+227
+105% +$7.1M 0.97% 30
2014
Q3
$6.76M Hold
217
0.64% 33
2014
Q2
$5.97M Hold
217
0.39% 39
2014
Q1
$6.54M Hold
217
0.51% 36
2013
Q4
$7.65M Hold
217
0.67% 30
2013
Q3
$5.13M Buy
+217
New +$6.99M 0.54% 30

Other funds holding BIOL